In 2019, the International Neuroendocrine Cancer Alliance (INCA) conducted an online self-reported survey: 2359 NET patients and 436 healthcare professionals (HCPs) from 68 countries across 6 continents, in 14 languages.
Find out more about SCAN 2019 insights presented in infographics and videos in 11 languages
SCAN 2019 was a global assessment:
- among NET patients & healthcare professionals
- by a self-administered online questionnaire
- available in 14 languages: Arabic, Bulgarian, Chinese, Dutch/Flemish, French, English, German, Hindi, Japanese, Italian, Portuguese, Russian, Spanish, Swahili
SCAN key measurements:
- The availability of NET diagnostic tools
- The level of access to NET treatments
- The level of access to ongoing checks
- The level of access to healthcare professionals
- Out-of-pocket costs of NET treatment and care
- The provision of supportive services
- Leading healthcare issues NET patients face today
In 2025, INCA will launch a replication of the SCAN survey to compare the results on the same key measurements.
The questionnaires in 2025 will be available in English, Arabic, Bulgarian, simplified Chinese, traditional Chinese, Dutch, French, German, Hindi, Italian, Japanese, Portuguese, Russian, Spanish and Swahili.
Download the SCAN 2025 teaser flyer to inform your community!
Stay tuned for the launch of SCAN 2025!